Benjamin P. Chen, PhD

Panacea Healthcare Venture

Dr. Benjamin Chen is a scientist, entrepreneur, investor, and merchant banker.   He was most recently the CEO of ImaginAb, Inc. a ventured-backed company developing a cutting-edge platform to address an urgent unmet need in immuno-oncology.  Prior to that, he served as the Chairman and CEO of London-based Immune Targeting Systems, Ltd., leading the immune therapy company through significant strategic growth, innovative product development, and establishing a presence in France and North America. Before his return to operational roles, he spent nine years as a Managing Director at Burrill & Company, a global life sciences venture firm where he evaluated investment opportunities and assisted a global clientele in completing licensing, partnering and M&A transactions. He also played a key role in establishing the Malaysian Life Sciences Fund I and served as a director. Earlier in his career as an R&D executive, he had experience in building talented research teams in immunology, stem cell biology, genomics, gene therapy, and molecular diagnostics in both biotechnology start-ups and multinational pharmaceutical companies, including Roche Diagnostics and Novartis.

Ben received his academic training in Microbiology and Immunology at the University of Wisconsin-Madison and Stanford University